The next board meeting for 4D Molecular Therapeutics Inc is on 09 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment ConferenceSee details
4D Molecular Therapeutics Inc has a share price target of US$ 30, revenue growth forecast of 8700.0%, and profit growth estimate of -31.0% for FY25, based on top 12 analyst calls.